CPA CPA - Flora Growth Chief Officer
| FLGC Stock | USD 1.05 0.04 3.96% |
Insider
CPA CPA is Chief Officer of Flora Growth Corp
| Address | 3406 SW 26th Terrace, Fort Lauderdale, FL, United States, 33132 |
| Phone | 954 842 4989 |
| Web | https://www.floragrowth.com |
Flora Growth Management Efficiency
The company has return on total asset (ROA) of (0.1662) % which means that it has lost $0.1662 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.3537) %, meaning that it created substantial loss on money invested by shareholders. Flora Growth's management efficiency ratios could be used to measure how well Flora Growth manages its routine affairs as well as how well it operates its assets and liabilities. As of December 24, 2024, Return On Tangible Assets is expected to decline to -2.64. The current year's Return On Capital Employed is expected to grow to -6.51. At present, Flora Growth's Net Tangible Assets are projected to increase significantly based on the last few years of reporting. The current year's Non Currrent Assets Other is expected to grow to about 84 K, whereas Non Current Assets Total are forecasted to decline to about 2.1 M.Similar Executives
| Showing other executives | INSIDER Age | ||
| Edward III | Fate Therapeutics | 48 | |
| Mark DVM | Fate Therapeutics | 63 | |
| Andreas Bergthaler | Hookipa Pharma | N/A | |
| Prof MD | Hookipa Pharma | 80 | |
| Jason MBA | Caribou Biosciences | 56 | |
| Richard MD | X4 Pharmaceuticals | 61 | |
| Mr MS | Karyopharm Therapeutics | N/A | |
| Sharon MBA | Karyopharm Therapeutics | 54 | |
| Ruhi MBA | Caribou Biosciences | 49 | |
| Keith MD | X4 Pharmaceuticals | 53 | |
| Renato Skerlj | X4 Pharmaceuticals | N/A | |
| MS MBA | Fate Therapeutics | N/A | |
| Christine MBA | Hookipa Pharma | 59 | |
| Lukas Flatz | Hookipa Pharma | N/A | |
| Cindy Hayashi | Caribou Biosciences | N/A | |
| Syed MD | Caribou Biosciences | 57 | |
| YuWaye MD | Fate Therapeutics | N/A | |
| RPh RPh | Karyopharm Therapeutics | 55 | |
| Joern Aldag | Hookipa Pharma | 65 | |
| Arthur Taveras | X4 Pharmaceuticals | 60 | |
| Mansoor MD | Karyopharm Therapeutics | 63 | |
Management Performance
| Return On Equity | -1.35 | ||||
| Return On Asset | -0.17 |
Flora Growth Corp Leadership Team
Elected by the shareholders, the Flora Growth's board of directors comprises two types of representatives: Flora Growth inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Flora. The board's role is to monitor Flora Growth's management team and ensure that shareholders' interests are well served. Flora Growth's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Flora Growth's outside directors are responsible for providing unbiased perspectives on the board's policies.
| CPA CPA, Chief Officer | ||
| Holly Bell, Vice Affairs | ||
| Manfred Ziegler, Managing Director | ||
| Matthew Cohen, G Counsel | ||
| Aaron Atin, Corporate Secretary | ||
| Javier Franco, VP Agriculture | ||
| FCA FCA, Advisor | ||
| Clifford Starke, CEO Director | ||
| James Choe, Chief Officer | ||
| Luis Merchan, CEO Pres | ||
| Dany Vaiman, Chief Officer | ||
| Jessie Casner, Chief Officer |
Flora Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Flora Growth a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -1.35 | ||||
| Return On Asset | -0.17 | ||||
| Profit Margin | (0.22) % | ||||
| Operating Margin | (0.20) % | ||||
| Current Valuation | 19.06 M | ||||
| Shares Outstanding | 17.28 M | ||||
| Shares Owned By Insiders | 23.02 % | ||||
| Shares Owned By Institutions | 3.38 % | ||||
| Number Of Shares Shorted | 403.55 K | ||||
| Price To Book | 4.23 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Flora Growth Corp offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Flora Growth's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Flora Growth Corp Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Flora Growth Corp Stock:Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Flora Growth Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Flora Growth. If investors know Flora will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Flora Growth listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.35) | Revenue Per Share 7.41 | Quarterly Revenue Growth (0.27) | Return On Assets (0.17) | Return On Equity (1.35) |
The market value of Flora Growth Corp is measured differently than its book value, which is the value of Flora that is recorded on the company's balance sheet. Investors also form their own opinion of Flora Growth's value that differs from its market value or its book value, called intrinsic value, which is Flora Growth's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Flora Growth's market value can be influenced by many factors that don't directly affect Flora Growth's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Flora Growth's value and its price as these two are different measures arrived at by different means. Investors typically determine if Flora Growth is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Flora Growth's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.